TOP STORIES

• REGULATORY MHLW to Launch New Public-Private Confab Focusing on Drug Pricing
  April 10, 2018

• ORGANIZATION Company Category Criteria for Price Maintenance Premium Tough on Ophthalmic Drug Makers: Industry Group
  April 9, 2018

• BUSINESS Alfresa to Fully Introduce Distribution Cost Analysis System; Will “Raise Reps’ Awareness of Importance of Price Negotiations”: Pres.
  April 9, 2018

• REGULATORY MEXT to Support Establishment of “Open Innovation Organizations” at Universities
  April 6, 2018

• REGULATORY MHLW Panel to Kick Off Debates on Amendment of Pharmaceuticals and Medical Devices Law
  April 5, 2018

• TRENDS Eisai’s Nichi-Iko Deal Marks Watershed in Generic Biz of Research-Driven Makers
  April 3, 2018

• BUSINESS Keytruda Filed for Tumor-Agnostic Indication in Japan
  April 2, 2018

• TRENDS Lilly Japan Joins Top 10 List for 1st Time, Sales Triple in 10 Years on Successive Launches
  March 30, 2018

• BUSINESS Eisai to Quit Generic Supply Biz, Transfer Subsidiary to Nichi-Iko
  March 29, 2018

• BUSINESS Takeda Mulls Takeover Bid for Shire
  March 29, 2018

• REGULATORY Sakigake Status Goes to World’s 1st Renal-Function Improving Agent, BBB-Penetrating Hunter Syndrome Med and 4 More Drugs
  March 28, 2018

• BUSINESS JCR Shooting for Big Chunk of 900 Billion Yen Global Lysosome Storage Disease Market with J-Brain Cargo
  March 27, 2018

• REGULATORY 16 Possible Topics for New Guidelines Including Continuous Manufacturing to Be Discussed at First ICH “Interim Meeting” this Week
  March 26, 2018

• BUSINESS Lilly Japan Sales Up 7% in 2017, Upbeat Biz Fueled by Global Simultaneous Development
  March 23, 2018

• BUSINESS Single Generic Pricing Rule Will Accelerate Unreasonable Price Raises: Sawai Chief
  March 22, 2018

• BUSINESS Toho to Thoroughly Implement Drug Distribution GL, Focus on Cost-Cutting in Response to Impact of Drug Pricing Reform: Pres.
  March 20, 2018

• REGULATORY MHLW Health Policy Chief Questions Volume-Focused Sales Strategies, Urges Drug Makers to Shift to Healthy Lifespan Extension
  March 19, 2018

• BUSINESS Shionogi Nabs Rights to Osaka Upstart’s Tissue Regeneration-Inducing Peptide
  March 16, 2018

• BUSINESS Japan Likely the Only Negative Growth Pharma Market in 2018-2022: IQVIA
  March 16, 2018

• BUSINESS Shionogi’s Single-Dose Flu Med Xofluza Hits Japan Shelves
  March 15, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 148
• 149
• 150
• 151
• 152
• 153
• 154
• 155
• 156
• …
• Next ›
• 最終 »